Aptus International Enhanced Yield ETF (IDUB) Options

Schumer is getting disemboweled on Bluesky.

It is something to behold.

It just isn’t anger over his decision to vote for the CR.

There is a loud chorus calling for him to be primaried, for him to be forced out of his job as minority leader, or for him to

$SAPX https://youtu.be/_cUKCLbfK5w?si=FCTsRWbDUU_iEjhe

$GOTRF Hot one here

Ellis Martin Report:Goliath Resources Drills 9.39 g/t AuEq 10.17 Meters-McEwen Mining Invests $10Mil

The Goliath booth was the talk of the town at PDAC this year.
Their might be something here for us.

https://www.youtube.com/wat

I agree with you... but Borophene is possible also. .. maybe further away.. then again maybe not.

Yes, that was a statement regarding escrow. I do believe you live in the present.

They plan on uplisting?

I do live in the present....that is why I have Coop stock.........and it is at 100.00 and will rise....Coop is the Tell...

A question keeps arising that no one officially answers.

Who* actually OWNS Affluence Corporation?
First Durham Black was purportedly going to own it through a Reverse Merger, then Patrick Shutt's unwinding heralded new INDEPENDENT DIRECTORS for AFFU's management as Honan and

Ellis Martin Report:Goliath Resources Drills 9.39 g/t AuEq 10.17 Meters-McEwen Mining Invests $10Mil

The Goliath booth was the talk of the town at PDAC this year.
Their might be something here for us.

https://www.youtube.com/watch?v=W2PHtEQg2a4

Ma

you know what you expect from Elon to save...Huge belief that he can Help..

Who else

God Bless

good stuff

I asked Gemini about project Orbis and approval

It's important to understand that the FDA's Oncology Center of Excellence (OCE) doesn't receive regulatory applications directly. Instead, drug sponsors submit applications to the appropriate FDA product center (like the Center for Drug

Ellis Martin Report:Goliath Resources Drills 9.39 g/t AuEq 10.17 Meters-McEwen Mining Invests $10Mil

The Goliath booth was the talk of the town at PDAC this year.
Their might be something here for us.

https://www.youtube.com/watch?v=W2PHtEQg2a4

Ma

Had the opportunity to study the transcript of Yves LeMaitre’s presentation. Some positive take always:
1. Industry recognized need for new materials, polymers on top of the list based on feed back from biggest companies in the field. Polymers will ‘ shine’ with need for ever higher bandwidth

So you are suppose to get excited, cheer, clap, celebrate, sing hallelujah with this. It's nothing. He has nothing. And when he does, have something, for real, that looks positive I'll say so. But when he puts out a disaster financial report will you say it was poor?


https://i

Actually, I'm fascinated by watching this unfolding Deconstruction Period. I actually think it aligns with our requirement for justice. I will greatly look forward to seeing communications re-established with investors.

Does CLIS have or had any relationship with WNRS?

NFTM

https://youtu.be/_cUKCLbfK5w?si=FCTsRWbDUU_iEjhe

Future view, SPY 520 and 500 offer rough

watch areas for down side support...

but only if market retreat continues...

everyone may be silly for worry over

higher prices ahead...

how the broader market reacts may be

Manibiotech, I understand what you’re trying to say. You believe it is better to have everything under one company. However, copilot doesn’t agree with your philosophy. See below and note the penultimate paragraph. It’s called strategy.

it's accurate that Northwest Biotherapeuti

C.S. Lewis — 'You can't go back and change the beginning but you can start where you are and change the ending.'

Lodas

I see what appears to be an error at paragraph 0022.
States that by age forty brain atrophy has reached a rate of 5%
“annually”.

This should read 5% per decade.

I've followed Marc for almost 5 years and long ago gave up trying to figure him out. He also put $120k into the company last October and the properties haven't sold since then.

I know that I've heard him lay out very reasonable plans for the company in presentations only to follow it